February 14, 2024
Ono Pharmaceutical said on February 13 that it has signed a drug discovery collaboration and option agreement with Texas-based Shattuck Labs aiming to create bifunctional fusion proteins for pathways involved in autoimmune and inflammatory illnesses. Under the pact, Shattuck will...read more